GCK and type 2 diabetes mellitus: Using the upper limit of the age-appropriate reference ranges (56 mmol/mol (7.3%)) for those aged ≤40 years (60 mmol/mol (7.6%)) and for those aged >40years to discriminate those with a GCK mutation from those with T1D/T2D correctly identified 97% of subjects with a mutation.